These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 172848)

  • 1. Sphingomyelinases in human tissues. II. Absence of a specific enzyme from liver and brain of Niemann-Pick disease, type C.
    Callahan JW; Khalil M; Philippart M
    Pediatr Res; 1975 Dec; 9(12):908-13. PubMed ID: 172848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelinases in human tissues. III. Expression of Niemann-Pick disease in cultured skin fibroblasts.
    Callahan JW; Khalil M
    Pediatr Res; 1975 Dec; 9(12):914-8. PubMed ID: 172849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niemann-Pick disease type D: lipid analyses and studies on sphingomyelinases.
    Rao BG; Spence MW
    Ann Neurol; 1977 Apr; 1(4):385-92. PubMed ID: 31133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates.
    Besley GT; Moss SE
    Biochim Biophys Acta; 1983 Jun; 752(1):54-64. PubMed ID: 6303436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An animal model of human acid sphingomyelinase deficiency (Niemann-Pick disease) and the study of its enzyme replacement (the Japan Society of Human Genetics award lecture).
    Kitagawa T
    Jinrui Idengaku Zasshi; 1987 Jun; 32(2):55-69. PubMed ID: 2830422
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial purification of acid sphingomyelinase from normal and pathological (M. Niemann-Pick type C) human brain.
    Müller H; Harzer K
    J Neurochem; 1980 Feb; 34(2):446-8. PubMed ID: 6251170
    [No Abstract]   [Full Text] [Related]  

  • 7. Sphingomyelinase isozymes of human tissues: a phpothesis on enzymatic differentiation of the neuropathic and non-neuropathic forms of Niemann-Pick disease.
    Yamaguchi S; Suzuki K
    Biochem Biophys Res Commun; 1977 Aug; 77(3):999-1003. PubMed ID: 197954
    [No Abstract]   [Full Text] [Related]  

  • 8. Sphingomyelinases and the genetic defects in Niemann-Pick disease.
    Callahan JW; Khalil M
    Adv Exp Med Biol; 1976; 68():367-78. PubMed ID: 7108
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromatofocusing of skin fibroblast sphingomyelinase: alterations in Niemann-Pick disease type C shared by GM1-gangliosidosis.
    Vanier MT; Rousson R; Louisot P
    Clin Chim Acta; 1983 May; 130(2):155-61. PubMed ID: 6307547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
    Poulos A; Ranieri E; Shankaran P; Callahan JW
    Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niemann-Pick disease: prenatal diagnoses and studies of sphingomyelinase activities.
    Wenger DA; Wharton C; Sattler M; Clark C
    Am J Med Genet; 1978; 2(4):345-56. PubMed ID: 233699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of acid sphingomyelinase in the mitochondria-lysosome fraction of brain from Niemann-Pick mice.
    Tsuda M; Owada M; Kitagawa T; Miyawaki S
    J Inherit Metab Dis; 1985; 8(3):147-8. PubMed ID: 3027450
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte enzymes in the detection of Niemann-Pick Carriers.
    Hardy B; Hoffman J; Neri A
    Biomed Pharmacother; 1982; 36(8-9):372-5. PubMed ID: 7182017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.
    Gal AE; Brady RO; Hibbert SR; Pentchev PG
    N Engl J Med; 1975 Sep; 293(13):632-6. PubMed ID: 239343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelinase in cultured skin fibroblasts from normal and Niemann-Pick type C patients.
    Poulos A; Hudson N; Ranieri E
    Clin Genet; 1983 Oct; 24(4):225-33. PubMed ID: 6315279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease.
    Poulos A; Shankaran P; Jones CS; Callahan JW
    Biochim Biophys Acta; 1983 May; 751(3):428-31. PubMed ID: 6303435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental Niemann-Pick rat: additional studies on the specificity of the sphingomyelinase reduction in rats treated with AY 9944 (author's transl)].
    Watanabe K; Sakuragawa N; Arima M
    No To Shinkei; 1981 Jun; 33(3):585-93. PubMed ID: 6167277
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and biochemical diagnostics of Niemann-Pick disease.
    Maciejko D; Tylki-Szymańska A
    Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type C Niemann-Pick disease in 2 siblings. Biochemical bases of its diagnosis].
    Pámpols T; Pineda M; Ferreter M; Fernández E
    An Esp Pediatr; 1986 Apr; 24(4):250-6. PubMed ID: 3014938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.